Hypertension (high blood pressure) Board decisions

The Board granted a Level 2 stipend in the PCAFC program for the Veteran due to his need for continuous supervision, protection, or instruction as determined by the April 2023 VFAI evaluation.

The Veteran's appeal is remanded for further development regarding his claims of service connection and increased rating, as well as earlier effective date issues. The Board finds pre-decisional duty to assist errors in the current record.

The Board has decided to remand the case due to a duty-to-assist error, and will consider the evidence of record at the time of the November 2020 rating decision.

The Board has found that there is not substantial compliance with the most recent remand directives and has decided to remand the case for further action, including obtaining updated VA and private treatment records and requesting a medical opinion regarding the service connection claim for hypertension.

The Board denied compensation under 38 U.S.C. § 1151 for sinusitis with neoplastic mass, chronic kidney disease, electrolyte disorder, and hypertension due to a lack of current disability or causation.,The Veteran's claims were remanded multiple times but the evidence did not support finding any qualifying additional disabilities.

The Veteran's service-connected disabilities did not render her unable to secure and follow a substantially gainful occupation prior to March 14, 2017.

The Board has reopened the claims for service connection for diabetes mellitus, hypertension, right upper extremity peripheral neuropathy, and left upper extremity peripheral neuropathy. The claims are being remanded due to the need to determine the Veteran's exposure to toxic chemicals at Guantanamo Bay, Cuba, naval facility.

The Veteran's heart disability and hypertension are granted as secondary to his service-connected PTSD. The claims for presumptive service connection based on herbicide exposure are denied.

The Board has remanded the Veteran's claims for service connection and increased rating for sleep apnea, arthritis of the hands and knees, hypertension, diabetic nephropathy, and bulging discs due to a lack of VA medical examinations.

The Veteran's Barrett's esophagus, GERD, sleep apnea, and hypertension are related to his military service including exposure to contaminated water at Camp Lejeune. The Board has determined that a VA examination is needed for these claims.

The Board has remanded the claims of service connection for ischemic heart disease and hypertension due to potential exposure in the Republic of Vietnam, as well as new evidence received since the last decision.

The Veteran's hypertension is granted as service connected due to exposure to Agent Orange during his military service. The PACT Act has been applied, but the effective date remains to be determined by the AOJ.

The Veteran's hypertension, which is service-connected and not due to herbicide exposure or the PACT Act, has been rated at 10 percent since August 10, 2022. The Board found that the evidence was at least equally balanced in favor of a finding that the Veteran's diastolic blood pressure predominantly reached 100 or more, requiring continuous medication for control.

The Veteran's claim for an earlier effective date for service connection of hypertension is denied as the evidence does not show that he submitted a valid claim within one year prior to August 10, 2022, when the PACT Act took effect. The effective date remains at August 10, 2022.

The Veteran's claims for service connection for headaches, gastrointestinal problems, and hypertension are being remanded due to inadequate examination reports and the need for new medical opinions.

The Veteran's claim for service connection for bilateral plantar fasciitis has been denied as there is no current diagnosis of the condition.,The Veteran's claims for service connection for hypertension and erectile dysfunction have been remanded due to potential exposure to toxic substances during service.

The Veteran's claim for an earlier effective date for service connection of hypertension is denied as the evidence does not show that he submitted a valid claim within one year prior to August 10, 2022, when the PACT Act took effect. The effective date remains at August 10, 2022.

The Veteran's hypertension was previously granted under the PACT Act, but he is seeking direct service connection. The Board finds a remand necessary to obtain an updated medical opinion considering the 2018 NAS Update.

The Veteran's applications to reopen and readjudicate claims for service connection for acne, heart disorder (congestive heart failure with hypertrophy), GERD, and hypertension have been granted. The application for vitamin B-12 deficiency has been denied.

The Board has granted service connection for hypertension and residuals of prostate cancer based on the presumption of exposure to herbicide agents due to service in or near the Korean DMZ.